Concepedia

Jeffrey E. Kropf

JE

Statistics

Publications

11

Citations

833

H-Index

11

Active since

1998

Affiliations

Gilead Sciences (United States)(Current)

Jeffrey E. Kropf is an author at Gilead Sciences (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1998–2020

11

Publications

11

Specific Btk inhibition suppresses B cell– and myeloid cell–mediated arthritis

Julie A. Di Paolo, Tao Huang, Mercedesz Balázs et al. · Nature Chemical Biology · 2010 · 328 citations · Full text

, , +11

Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase

Kevin Currie, Jeffrey E. Kropf, Tony Lee et al. · Journal of Medicinal Chemistry · 2014 · 167 citations · Full text

, , +18

Potent and selective Bruton’s tyrosine kinase inhibitors: Discovery of GDC-0834

Wendy B. Young, J A Barbosa, Peter Blomgren et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 64 citations · Full text

, , +11

Studies on a Total Synthesis of the Microbial Immunosuppresive Agent FR901483

Jeffrey E. Kropf, I.C. Meigh, M. W. P. Bebbington et al. · The Journal of Organic Chemistry · 2006 · 52 citations · Full text

Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune Diseases

Peter Blomgren, Jayaraman Chandrasekhar, Julie A. Di Paolo et al. · ACS Medicinal Chemistry Letters · 2020 · 49 citations · Full text

, , +15

1–5 of 11